Raphael J Mannino - Net Worth and Insider Trading
Raphael J Mannino Net Worth
The estimated net worth of Raphael J Mannino is at least $973,911 dollars as of 2024-09-20. Raphael J Mannino is the Executive Vice President & CSO of BioDelivery Sciences International Inc and owns about 155,009 shares of BioDelivery Sciences International Inc (BDSI) stock worth over $866,500. Raphael J Mannino is also the Chief Scientific Officer of Matinas BioPharma Holdings Inc and owns about 28,491 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $107,411. Details can be seen in Raphael J Mannino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raphael J Mannino has not made any transactions after 2017-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raphael J Mannino
Raphael J Mannino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raphael J Mannino owns 2 companies in total, including Matinas BioPharma Holdings Inc (MTNB) , and BioDelivery Sciences International Inc (BDSI) .
Click here to see the complete history of Raphael J Mannino’s form 4 insider trades.
Insider Ownership Summary of Raphael J Mannino
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2017-09-11 | Chief Scientific Officer |
BDSI | BioDelivery Sciences International Inc | 2008-07-24 | director & Executive VP & CSO |
Raphael J Mannino Latest Holdings Summary
Raphael J Mannino currently owns a total of 2 stocks. Among these stocks, Raphael J Mannino owns 155,009 shares of BioDelivery Sciences International Inc (BDSI) as of April 12, 2004, with a value of $866,500 and a weighting of 88.97%. Raphael J Mannino also owns 28,491 shares of Matinas BioPharma Holdings Inc (MTNB) as of September 11, 2017, with a value of $107,411 and a weighting of 11.03%.
Latest Holdings of Raphael J Mannino
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BDSI | BioDelivery Sciences International Inc | 2004-04-12 | 155,009 | 5.59 | 866,500 |
MTNB | Matinas BioPharma Holdings Inc | 2017-09-11 | 28,491 | 3.77 | 107,411 |
Holding Weightings of Raphael J Mannino
Raphael J Mannino Form 4 Trading Tracker
According to the SEC Form 4 filings, Raphael J Mannino has made a total of 0 transactions in BioDelivery Sciences International Inc (BDSI) over the past 5 years. The most-recent trade in BioDelivery Sciences International Inc is the sale of 27,600 shares on April 12, 2004, which brought Raphael J Mannino around $109,572.
According to the SEC Form 4 filings, Raphael J Mannino has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 100 shares on September 11, 2017, which cost Raphael J Mannino around $7,050.
Insider Trading History of Raphael J Mannino
- 1
Raphael J Mannino Trading Performance
GuruFocus tracks the stock performance after each of Raphael J Mannino's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raphael J Mannino is 2.19%. GuruFocus also compares Raphael J Mannino's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raphael J Mannino within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Raphael J Mannino's insider trading performs compared to the benchmark.
Performance of Raphael J Mannino
Raphael J Mannino Ownership Network
Raphael J Mannino Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Raphael J Mannino is the Chief Scientific Officer of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , director & Chief Executive Officer Jerome D Jabbour , and Chief Financial Officer Keith A Kucinski .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Raphael J Mannino Mailing Address
Above is the net worth, insider trading, and ownership report for Raphael J Mannino. You might contact Raphael J Mannino via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster Nj 07921.